Morningstar

SK Life Science Presents Cenobamate Research at the 2024 American Epilepsy Society (AES) Annual Meeting

SK Life Science will also host the "Prioritizing Seizure Treatments Through Real-World Patient Case Studies Symposium," an expert led panel to advance the discussion regarding the unmet need for ...

SK hynix, Sandisk kick off standardization of HBF

SK hynix and Sandisk have teamed up for the global standardization of high-bandwidth flash (HBF), which is viewed as a new ...
FiercePharma

SK Life Science kicks Xcopri sales into high gear with new campaign

It’s boots on the ground, or rather in the office, for SK Life Science’s latest sales push aimed at getting its target, i.e., neurologists, to pay attention. The unconventional approach of “The Shoe ...

SK hynix adds $15 bil. investment to Yongin cluster, total reaches $21 bil.

SK hynix will invest 21.6 trillion won ($15.07 billion) by 2030 to build five additional clean rooms for its first fab in its Yongin ...
Morningstar

SK Life Science, Inc. to Present 10 Posters with New Cenobamate Data, Including a Late-Breaker, at the 2025 American Epilepsy Society (AES) Annual Meeting

PARAMUS, N.J., Nov. 21, 2025 /PRNewswire/ -- SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., Ltd., will ...
Business Insider

SK Life Science Labs Experts Unveil Latest Scientific Findings at Keystone Symposia on Epigenetic Mechanisms and Cancer Treatment, and the 2nd Annual Molecular Glue Drug ...

KING OF PRUSSIA, Pa., Feb. 08, 2024 (GLOBE NEWSWIRE) -- SK Life Science Labs (formerly Proteovant Therapeutics) a subsidiary of SK Biopharmaceuticals, Co., Ltd., showcased its cutting-edge targeted ...
Business Insider

SK Life Science Labs to Present Four Preclinical Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024

KING OF PRUSSIA, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- SK Life Science Labs, a subsidiary of SK Biopharmaceuticals, Co., Ltd., a global biotech focused on the research, development, and ...
Hosted on MSN

SK bioscience and Sanofi extend partnership to develop next-gen vaccines

SK Bioscience CEO Ahn Jae-yong, left, and Sanofi's Jean-Francois Toussant, global head of vaccine research and development, pose for the photo after a signing ceremony. [SK BIOSCIENCE] SK bioscience ...
FiercePharma

SK Life Science starts TV ad campaign to drive patients to seizure drug Xcopri

SK Life Science is encouraging patients beetling down the long and winding road toward seizure-free life to switch gears. In a new nationwide direct-to-consumer (DTC) ad, the Xcopri manufacturer asks ...
조선일보

SK bioscience and Sanofi launch MenQuadfi meningococcal vaccine in Korea

SK bioscience said on the 9th that it introduced the quadrivalent meningococcal conjugate vaccine "MenQuadfi" in Korea in cooperation with Sanofi Korea. The vaccine can be given from 6 weeks of age ...
KXAN

SK Life Science Labs Announces the Publication in Nature Communications of its Breakthrough Research on Molecular Glue Discovery to Advance Cancer Immunotherapy

KING OF PRUSSIA, Pa., May 1, 2025 /PRNewswire/ -- SK Life Science Labs, a subsidiary of SK Biopharmaceuticals Co., Ltd., a global biotech focused on the research, development, and commercialization of ...
Nature

SK Life Science Labs

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Identify research insights to guide ...